Posts in tag

cardiovascular disease


Breathlessness is a cardinal symptom for cardiorespiratory diseases, leading to a cycle of physical deconditioning, anxiety and depression. Pharmacological and non-pharmacological interventions can reduce stress and improve quality of life. …

‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 …

Pulmonary hypertension can be a devastating disease that is easily missed in the early stages because of its typically nonspecific presentation with gradually increasing dyspnoea. Early diagnosis and treatment are …

A pharmacist intervention for patients at high risk of cardiovascular disease both improves patient outcomes and saves money, according to new research Pharmacist researchers from Canada have developed a model …

Getting enough sleep is important… but getting too much could be risky, new research shows A study of more than 116,000 people in seven regions of the world, published in …

Reports show 19 deaths occurred due to sildenafil in the UK last year. What does this mean for the medicine, which is being considered for S3 status in Australia? Data from …

A study of more than 131,000 patients has found pharmacists were able to alleviate GP workload by following up new hypertensive prescriptions In the UK, the New Medicine Service (NMS) …

Are CVD-related deaths going up or down? Here’s the latest based on data collected between 1980 and 2015 1. Death rates from cardiovascular disease have fallen considerably since the late …

The TGA has knocked back applications for the drugs to go OTC, citing need for medical practitioners to be involved Applications were submitted for both sildenafil (50 mg) and PDE5 …

Methamphetamine combined with prescription drugs poses potentially fatal risks including cardiac arrhythmia Methamphetamine-related deaths continue to rise across the country. The number of deaths in Australia doubled between 2009 and …

A relatively new drug has been found to greatly reduce risk of cardiovascular and kidney disease – though it comes with risks of its own Canagliflozin (Invokana) is a SGLT2 …

Recent findings that NSAIDs increase risk of heart attack have minimal implications, argues ASMI A recent BMJ study found that all non-steroidal anti-inflammatory drugs (NSAIDs), including over-the-counter medicines such as …